Orismilast may be an effective and safe novel treatment option for adult patients with moderate to severe atopic dermatitis.

A systematic review confirmed the safety and efficacy of a pulsed dye laser for the treatment of port-wine birthmarks and infantile hemangiomas.

The Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics License Application (sBLA) for dupilumab to treat adults with bullous pemphigoid.

A study has found that patients with ischemic stroke and COVID-19, compared with patients without COVID-19, experience worse recovery outcomes.

Formulation characteristics can explain the observed variation in benzene levels of over-the-counter benzoyl peroxide-containing products.

Federal funding for medical research has dropped by $1 billion this year, raising alarm among universities, medical centers, and lawmakers.

Trump decided to keep the government's free COVID test program running, just minutes before COVIDtests.gov was set to shut down.

Those with a history of depression have more physical health conditions and develop additional physical conditions at a faster rate.